Drugs@FDA: FDA-Approved Drugs
Abbreviated New Drug Application (ANDA): 213566
Company: MACLEODS PHARMS LTD
Company: MACLEODS PHARMS LTD
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
---|---|---|---|---|---|---|---|
NYSTATIN | NYSTATIN | 100,000 UNITS/GM | CREAM;TOPICAL | Prescription | AT | No | No |
Original Approvals or Tentative Approvals
Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
---|---|---|---|---|---|---|---|
08/10/2021 | ORIG-1 | Approval | STANDARD |
Label is not available on this site. |
NYSTATIN
CREAM;TOPICAL; 100,000 UNITS/GM
TE Code = AT
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | RLD | TE Code | Application No. | Company |
---|---|---|---|---|---|---|---|---|
NYSTATIN | NYSTATIN | 100,000 UNITS/GM | CREAM;TOPICAL | Prescription | No | AT | 062949 | ACTAVIS MID ATLANTIC |
NYSTATIN | NYSTATIN | 100,000 UNITS/GM | CREAM;TOPICAL | Prescription | No | AT | 061966 | COSETTE |
NYSTATIN | NYSTATIN | 100,000 UNITS/GM | CREAM;TOPICAL | Prescription | No | AT | 207733 | CROWN LABS INC |
NYSTATIN | NYSTATIN | 100,000 UNITS/GM | CREAM;TOPICAL | Prescription | No | AT | 062129 | FOUGERA PHARMS |
NYSTATIN | NYSTATIN | 100,000 UNITS/GM | CREAM;TOPICAL | Prescription | No | AT | 213566 | MACLEODS PHARMS LTD |
NYSTATIN | NYSTATIN | 100,000 UNITS/GM | CREAM;TOPICAL | Prescription | No | AT | 062225 | PADAGIS US |
NYSTATIN | NYSTATIN | 100,000 UNITS/GM | CREAM;TOPICAL | Prescription | No | AT | 064022 | TARO |
NYSTATIN | NYSTATIN | 100,000 UNITS/GM | CREAM;TOPICAL | Prescription | No | AT | 212557 | TORRENT |